ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

RSLS ReShape Lifesciences Inc

0.171
-0.0043 (-2.45%)
最終更新日: 03:13:38
15分遅延
名称 銘柄コード 市場 種別
ReShape Lifesciences Inc RSLS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.0043 -2.45% 0.171 03:13:38
始値 安値 高値 終値 前日終値
0.175 0.1686 0.179 0.1753
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0205:05GLOBEReShape Lifesciences® Reports Year Ended December 31, 2023..
2024/3/2821:31GLOBEReShape Lifesciences® Receives Notice of Allowance for..
2024/3/0422:31GLOBEReShape Lifesciences® Provides Update on 2024 Cost Reduction..
2024/2/2706:19EDGAR2Form 8-K - Current report
2024/2/2222:31GLOBEReShape Lifesciences® Announces First Surgeries Utilizing..
2024/1/2422:31GLOBEReShape Lifesciences® Conducts Bariatric Fellows Training..
2024/1/1906:38EDGAR2Form 8-K - Current report
2024/1/1708:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0606:14EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/12/2022:31GLOBEReShape Lifesciences® Engages Maxim Group LLC To Identify..
2023/12/1306:05GLOBEReShape Lifesciences® Receives FDA PMA Supplement Approval..
2023/11/3006:05EDGAR2Form 8-K - Current report
2023/11/2122:06GLOBEReShape Lifesciences® Enters into Warrant Exercise..
2023/11/0906:05GLOBEReShape Lifesciences® Reports Third Quarter Ended September..
2023/11/0622:31GLOBEReShape Lifesciences® to Announce Financial Results for the..
2023/10/1405:42EDGAR2Form 8-K - Current report
2023/10/0605:05EDGAR2Form 8-K - Current report
2023/10/0322:23EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
2023/9/3001:30GLOBEReShape Lifesciences® Announces Pricing of $3.0 Million..
2023/9/2806:30EDGAR2Form S-1/A - General form for registration of securities..
2023/9/2305:02EDGAR2Form 8-K - Current report
2023/9/2221:31GLOBEReShape Lifesciences® Announces Participation in the LD..
2023/9/2121:31GLOBEReShape Lifesciences® Signs Exclusive License Agreement With..
2023/9/1921:31GLOBEReShape Lifesciences® Significantly Strengthens Patent..
2023/9/1421:31GLOBEReShape Lifesciences® Receives NIH SBIR Grant to Further..
2023/8/2605:41EDGAR2Form S-1 - General form for registration of securities under..
2023/8/0806:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0805:54EDGAR2Form 8-K - Current report
2023/8/0805:05GLOBEReShape Lifesciences® Reports Second Quarter Ended June 30,..
2023/8/0405:05GLOBEReShape Lifesciences® to Announce Financial Results for the..
2023/6/2921:31GLOBEReShape Lifesciences® Signs Preferred Partner Agreement With..
2023/6/2821:31GLOBEReShape Lifesciences® Presents Data on its Proprietary..
2023/6/2705:05GLOBEReShape Lifesciences® Submits FDA PMA Supplement Application..
2023/6/2321:35GLOBELife Science Investor Forum: Presentations Now Available for..
2023/6/2023:58GLOBELife Science Investor Forum Agenda Announced for June 22nd
2023/6/1421:31GLOBEReShape Lifesciences® to Participate in Investor and..
2023/5/1605:05GLOBEReShape Lifesciences® Reports First Quarter Ended March 31,..
2023/5/1121:30GLOBEReShape Lifesciences® to Announce Financial Results for the..

最近閲覧した銘柄

Delayed Upgrade Clock